🧠 Japanese 🇯🇵 pharma company
#Sumitomo has received approval to mass-manufacture a pioneering
#StemCells treatment that regenerates dopamine-producing brain cells. Early trials showed over half of
#Parkinsons participants showing signs of recovery with no adverse effects. 🌟
Japan grants conditional appro...